SATURDAY 9 OCTOBER 2021
Plenary Session 2 The great wall of Fungi
Chairs: Carol Munro, UK & Julian Naglik, UK
08:30
PS2.1 Immune recognition of fungi: the writing on the wall
Neil Gow, UK, FECMM
09:00
PS2.2 Aspergillus cell wall
Top 10 papers
09:30
Clinical / diagnostics / treatment
Don Sheppard, USA, FECMM
09:30
Basic / immunology / genomics
Julian Naglik, UK, FECMM & Agostinho Carvalho, Portugal, FECMM
Quiz the expert sessions
10:15
Q01 PCR based diagnosis of invasive mold infection
Maurizio Sanguinetti, Italy & Sean Zhang , USA
10:15
Q02 Recurrent Vulvovaginal Candidiasis (VVC)
Riina Richardson, UK, FECMM
10:15
Q03 Clinical Mycology- How to get things going in LMICs
Rita Oladele, Nigeria, FECMM & Bright Ocansey, UK
10:15
Q04 Management of candida in the ICU
Luis Ostrosky-Zeichner, USA, FECMM
10:15
Q05 Mamangement stragegy in hematology
Marcio Nucci, Brazil, FECMM & Johan Maertens, Belgium, FECMM
10:15
Q06 Teaching Medical Mycology
Ester Segal, Israel, FECMM & June Kwon-Chung, USA
11:00
Poster session
12:00
Lunch break
12:30
Sponsored Integrated Symposium 2
More information on https://www.timm2021.org/sponsored-symposia/
14:15
Parallel Symposia 5-9
Symposium 5 Dermatophytes and fungal skin infections
Chairs: Sevtap Arikan Akdagli, Turkey, FECMM& Arunaloke Chakrabarti, India, FECMM
14:15
S05.1 Global epidemiology: What is changing, what is remarkable?
Rudramurthy Shivaprakash, India, FECMM
14:35
S05.2 How to determine MICs for my dermatophyte strain: Protocoles, tips, and trics
Sevtap Arikan Akdagli, Turkey, FECMM
14:55
S05.3 Primary immunodeficiencies and dermatophytoses: What else do we know?
Fanny Lanternier, France, FECMM
15:15
S05.4 Malassezia: epidemiology and host-response studies’
Dora Corzo-Leon, Scotland
Symposium 6 Immunity to fungi
Chairs: Agostinho Carvalho, Portugal, FECMM & Rebecca Drummond, UK
14:15
S06.1 Macrophage metabolism during Candida infection
Rebecca Drummond, UK
14:35
S06.2 Immuno genetics
Anna Puel, France
Symposium 7 Prophylaxis of Invasive Fungal Infections in Solid Organ Transplant Recipients
Chairs: Shahid Husain, Canada, FECMM
14:15
S07.1 Alternatives to drug treatment
Mihai Netea, the Netherlands
14:35
S07.2 Antifungal prophylaxis: Who, with what and how long?
Shmuel Shoham, USA
14:55
S07.3 Epidemiology
Shahid Husain, Canada, FECMM
Symposium 8 Update on diagnosis and treatment of chronic pulmonary aspergillosis (CPA)
Chairs: Aleksandra Barac, Serbia, FECMM
14:15
S08.1 Diagnostic Value of Galactomannan in Bronchoalveolar Lavage Fluid for Chronic Respiratory Disease with Pulmonary Aspergillosis
Aleksandra Barac, Serbia, FECMM
14:35
S08.2 Underlying Conditions and Clinical Spectrum of Chronic Pulmonary Aspergillosis (CPA)
14:55
S08.3 Prevalence of chronic pulmonary aspergillosis in patients with tuberculosis
Felix Bogomin, Uganda, FECMM
Symposium 9 Latest results of ECMM and international registries
Chair: Tamas Papp, Hungary
14:15
S09.1 Chief-Net
Yao Wang
14:30
S09.2 CPAnet
Eva van Braeckel, NL
14:45
S09.3 FungiNOS
Nina Khanna, CH
15:00
S09.4 CandiReg
Philipp Köhler, FECMM, DE
15:15
S09.5 Epidemiology of Candida glabrata resistance in France and Germany within the frame of the ARest consortium
Alexandre Alanio, FR
15:30
S09.6 FungiScope
15:45
Coffee break
16:15
Parallel Symposia 10-13
Symposium 10 Candida and other yeast infections
Chairs: Malcolm Richardson, UK, FECMM & Cornelia Lass Florl, Austria, FECMM
16:15
S10.1 Diagnosis of candida: Culture, BDG and Mannan
Liz Johnson, UK
16:35
S10.2 The role of PCR and T2 MR
Cornelia Lass Florl, Austria, FECMM
16:55
S10.3 Mixed Yeast infections - Common or not?
Ana Alastruey-Izquierdo, Spain, FECMM
17:15
S10.4 Epidemiology and Clinical Burden of Candida infections across Europe - Results of ECMM Candida III
Maiken Arendrup, Denmark
Symposium 11 The Myc(icr)obiome and Fungal Infections
Chairs: Anne Puel, France & Ilse Jacobsen, Germany
16:15
S11.1 The Lung mycobiom in health and disease
Paul Bowyer, UK
16:35
S11.2. Epidemiology of Fungal Infection in the ICU: Viral Infection a relevant risk factor?
Matteo Bassetti, Italy
16:55
S11.3 Mycobiome and invasive candidiasis
Tobias Hohl, USA, FECMM
17:15
S11.4 Mycobiome and microbial interactions
Ilse Jacobsen, Germany
Symposium 12 Viral infections and fungal disease
16:15
S12.1 Immunology
Frank van de Veerdonk, the Netherlands
16:35
S12.2 Definition, Diagnosis and Treatment of COVID-19 associated pulmonary aspergillosis- ECMM/ISHAM Consensus Guidance
Philipp Köhler, Germany, FECMM
16:55
S12.3 CMV
Arunaloke Chakrabarti, India, FECMM
Symposium 13 Emerging fungal issues
Chair: Anuradha Chowdhary, India, FECMM & Suzana Hadina, Hungary
16:15
S13.1 Emergomyces
Nelesh Govender, South Africa, FECMM
16:35
S13.2 Emerging rare yeasts in outbreaks
Anuradha Chowdhary, India, FECMM
16:55
S13.3 antifungal resistance
Matthew Fisher, UK, FECMM
18:00
Sponsored Integrated Symposium 3
More information on www.timm2021.org/sponsored-symposia
19:30
Sponsored reception